FDA Approves Implantable Continuous Glucose Monitoring System

The first-ever implantable continuous glucose monitoring system has been approved by the U.S. Food and Drug Administration (FDA). The Eversense Continuous Glucose Monitoring (CGM) system for use in people 18 years of age and older with diabetes will include a fully implantable sensor to detect glucose. It can be worn for up to 90 days.… Continue reading FDA Approves Implantable Continuous Glucose Monitoring System

Older Patients and Implantable Defibrillators

  Fewer one in 10 heart attack patients over 65 get an implantable defibrillator within a year of their heart attacks, according to a study from Duke Medicine. The most likely reasons for the low rate included advanced age, transitions in care between the hospital and an outpatient clinic, and a mandatory waiting period to… Continue reading Older Patients and Implantable Defibrillators